[Fund Index | Funds By Family | Fund Top Performers]

Mutual Fund Top Performers - Europe Stock

As of 30-Jun-08

Select a symbol for a detailed quote and links to additional information.

Top Performers - 3 Month (out of 122) Fund Name Symbol Return Third Millennium Russia I TMRIX 15.05% Third Millennium Russia TMRFX 15.05% Third Millennium Russia C TMRCX 14.73% ING Russia A LETRX 12.22% JPMorgan Russia R5 JRURX 10.37% JPMorgan Russia Select JRUSX 10.33% JPMorgan Russia A JRUAX 10.31% JPMorgan Russia C JRUCX 10.14% U.S. Global Accolade Eastern Europe EUROX 6.81% Forward Eastern Europe Equities Inst FEEIX 6.42%
Top Performers - 1 Year (out of 115) Fund Name Symbol Return Third Millennium Russia I TMRIX 32.55% Third Millennium Russia TMRFX 31.93% Third Millennium Russia C TMRCX 30.33% ING Russia A LETRX 27.99% JPMorgan Russia R5 JRURX 26.64% JPMorgan Russia Select JRUSX 26.46% JPMorgan Russia A JRUAX 26.14% JPMorgan Russia C JRUCX 25.51% U.S. Global Accolade Eastern Europe EUROX 9.09% Metzler/Payden European Emerging Markets MPYMX 3.53%		Top Performers - 3 Year (out of 102) Fund Name Symbol Ann. Ret. ING Russia A LETRX 49.52% Third Millennium Russia I TMRIX 37.08% Third Millennium Russia TMRFX 35.93% Third Millennium Russia C TMRCX 34.79% U.S. Global Accolade Eastern Europe EUROX 30.15% Metzler/Payden European Emerging Markets MPYMX 29.36% AIM European Small Company A ESMAX 19.57% Henderson European Focus A HFEAX 19.12% AIM European Small Company C ESMCX 18.68% AIM European Small Company B ESMBX 18.68%
Top Performers - 5 Year (out of 90) Fund Name Symbol Ann. Ret. ING Russia A LETRX 37.68% U.S. Global Accolade Eastern Europe EUROX 36.09% Metzler/Payden European Emerging Markets MPYMX 34.67% Third Millennium Russia TMRFX 33.51% AIM European Small Company A ESMAX 30.88% AIM European Small Company C ESMCX 29.94% AIM European Small Company B ESMBX 29.92% Henderson European Focus A HFEAX 25.76% DFA Continental Small Company I DFCSX 25.18% Eastern European Equity VEEEX 25.14%

Get Morningstar's portfolio tools, data, and editorial insights, plus Analyst Reports on 1,450 stocks and 2,000 funds. Start your free 14-day trial today.